ArticleMolecules (Basel, Switzerland)2022

Discovery of Quinacrine as a Potent Topo II and Hsp90 Dual-Target Inhibitor, Repurposing for Cancer Therapy.

Xin Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.